Related Experiment Video
Updated: Sep 14, 2025

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
Activation Mechanism Design for a Dual-Blood Pumping System for Pediatric Heart Failure
Thomas C Palazzolo1, Giselle C Matlis1, Ethan Pastor1
1BioCirc Research Laboratory, School of Biomedical Engineering, Science, and Health Systems, Drexel University, Philadelphia, Pennsylvania, USA.
Insights
This study introduces a novel double-blood pump ventricular assist device (VAD) for pediatric heart failure, demonstrating a low blood damage potential and effective in-situ actuation for improved patient outcomes.
Area of Science:
- Biomedical Engineering
- Pediatric Cardiology
- Medical Device Development
Background:
- Pediatric end-stage heart failure (HF) presents unique treatment challenges.
- Current mechanical circulatory support (MCS) devices show suboptimal outcomes in children compared to adults.
- A need exists for advanced MCS solutions tailored to pediatric patients.
Purpose of the Study:
- To develop and evaluate a novel double-blood pump ventricular assist device (VAD) for pediatric patients.
- To create a single-device solution offering effective support across various pediatric age ranges.
- To design an innovative activation mechanism for the secondary pump based on increased cardiac demand.
Main Methods:
- Utilized virtual studies to refine the activation mechanism design based on functional and anatomical constraints.
- Conducted iterative design improvements to meet performance targets.
- Performed in-vitro functional, hydraulic, and hemolytic flow loop testing to assess device performance and blood compatibility.
Main Results:
- The developed prototype demonstrated effective and repeatable in-situ actuation.
- The device provided leak-free support at physiological pressures and flows.
- Hemolytic testing indicated a low potential for blood damage.
Conclusions:
- The study validates the proposed activation mechanism for the novel VAD.
- The findings support the continued translational development of the Drexel Double Dragon VAD for pediatric application.
Objective:
Pediatric patients face significant challenges in the treatment of end-stage congenital or acquired heart failure (HF). Mechanical circulatory support (MCS) devices can serve as a bridge to transplant, but the few available MCS solutions are associated with deleterious patient outcomes when compared to adults. We are working to address this gap by developing a novel double-blood pump VAD to provide effective single-device support across the pediatric age range. Our innovative design integrates both an axial pump and a centrifugal pump in one implantable device and utilizes a unique mechanism to activate the secondary centrifugal pump as cardiac demands increase.
Methods:
We developed a configuration for the novel activation mechanism through virtual studies against functional requirements and anatomical fit constraints, iteratively improved the activation mechanism design to meet qualitative and quantitative design targets, evaluated the design through in vitro functional and hydraulic experimentation, and determined the hemolytic profile of the proposed design through hemolytic flow loop testing and analysis.
Results:
Multiple iterations of design improvements resulted in a prototype that could effectively and repeatably actuate in situ while providing leak-free support at physiological pressures and flows. Hemolytic testing demonstrated that the blood damage potential is low.
Conclusion:
The results from this study validate the proposed activation mechanism design and support the continued translational development of the Drexel Double Dragon VAD.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure VI: Adjunct Therapies

